Lovett Miller & Co. Completes $10 Million Equity Investment in Sigma International General Medical Apparatus, L.L.C.
Summary
Lovett Miller & Co. and its affiliated investors announced today that they have completed a $10 million equity investment in SIGMA International General Medical Apparatus, L.L.C. The SIGMA Spectrum and related proprietary software are designed specifically to prevent ADEs associated with administration of drugs delivered intravenously. "SIGMA has put together a superb team dedicated to delivering the safest, most effective and user friendly infusion pump on the market," said W. Scott Miller, Co-Managing Partner of Lovett Miller & Co. "We are very enthusiastic about the opportunity of being involved with this fast-growing company on the forefront of medical device technology." "We are very pleased to have the Lovett Miller team involved in helping us expand SIGMA. About Lovett Miller & Co. Lovett Miller & Co., co-headquartered in Jacksonville and Tampa, Florida, provides growth capital and shareholder liquidity for rapidly growing, privately held companies throughout the United States with a particular emphasis on Florida, Georgia and broader Southeastern marketplaces.